APR 17, 2020 9:15 PM PDT

Overcoming Multi-Drug Resistance in Cancer

WRITTEN BY: Nouran Amin

Resistance to chemotherapeutic use in caner patients is something that is inevitable. Continued resistance to these drugs results in poor prognosis and reduced survival rates.

For the past 35 years, scientists have been aiming to overcome multidrug resistance in cancer through a variety of experimental drugs. Some studies were successful in indicating that blocking the expression of certain genes can fight off tumor resistance to chemotherapeutics. However, that particular strategy has been warned to avoid according to a new research study carried by Scripps Research in Florida.

"With the help of our collaborators at New York University Medical Center, we looked at mouse immune cells from five major lymphoid and nonlymphoid tissues: bone marrow, thymus, spleen, lung, and small intestine," says lead author Mark Sundrud, PhD, associate professor of Immunology and Microbiology at Scripps Research. "It became clear that the types of cells that are key to fighting infections and cancers, are among those most sensitive to blocking MDR1 function."

Learn more about the role of the immune-system in fighting off cancer:

The study indicated that blocking the activity of a key gene, multidrug resistance-1 (MDR1), can hold negative effects on the immune system. These effects target the specialized immune cells called CD8+ cytotoxic T lymphocytes (CTLs).

“These insights become all the more pertinent today, given all the questions and concerns related to immunity against the pandemic coronavirus that causes COVID-19," Sundrud says.

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JUL 19, 2022
Drug Discovery & Development
Experimental Cancer Drug Regrows Nerves in Spinal Cord Injury
JUL 19, 2022
Experimental Cancer Drug Regrows Nerves in Spinal Cord Injury
An experimental cancer drug can regenerate damaged nerves following spinal trauma in mice and rats. The corresponding re ...
SEP 14, 2022
Drug Discovery & Development
Media Survey Panel vs. Media Screen
SEP 14, 2022
Media Survey Panel vs. Media Screen
Media Survey Panel vs. Media Screen: An Interview with R&D Scientist Catherine Nguyen on Benefit of Using a Media Survey ...
SEP 04, 2022
Neuroscience
The Facts About Fentanyl & Its Impact on the Brain
SEP 04, 2022
The Facts About Fentanyl & Its Impact on the Brain
You've probably heard of fentanyl, an extremely powerful, synthetic opioid that is used as a sedative, and sometimes ...
SEP 19, 2022
Genetics & Genomics
CGP: Simplifying the path from tumor to treatment
SEP 19, 2022
CGP: Simplifying the path from tumor to treatment
The promise of NGS in personalized cancer care For years, next-generation sequencing (NGS) has enabled oncologists to id ...
SEP 11, 2022
Plants & Animals
Potential Treatment for Chagas Disease
SEP 11, 2022
Potential Treatment for Chagas Disease
Chagas disease is a condition caused by a parasitic infection; specifically, the parasite Trypanosoma cruzi (T. cruzi), ...
OCT 03, 2022
Plants & Animals
Yeast Proteins Could Provide Clues for New Antifungal Development
OCT 03, 2022
Yeast Proteins Could Provide Clues for New Antifungal Development
Yeast, like bacteria, causes infections. In fact, yeasts are responsible for over 100 million infections every year. The ...
Loading Comments...